Delcath Systems competitorsClear all

Delcath Systems's top competitors include OncoStem Diagnostics, CollPlant and Bio-Path Holdings.
Delcath Systems
Delcath Systems
Delcath Systems is a specialty pharmaceutical and medical device company focused on oncology.
OncoStem Diagnostics
OncoStem Diagnostics
OncoStem Diagnostics is a diagnostic oncology company focused on discovering and developing novel tests for improved treatment planning.
CollPlant
CollPlant
CollPlant is a regenerative medicine company focused on 3D bioprinting of tissues and organs.
Bio-Path Holdings
Bio-Path Holdings
Bio-Path Holdings is a clinical and preclinical stage oncology focused antisense drug development company.
Founding Date
Founding Date
1988
Founding Date
2011
Founding Date
1981
Founding Date
2007
Type
Type
Public
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
New York, US HQ
Galway, IE
Queensbury, US
Locations
Bengaluru, IN HQ
Locations
Ness Ziona, IL HQ
New York, US
Locations
Bellaire, US HQ
Employees
Employees
437% decrease
Employees
244% decrease
Employees
39
Employees
811% decrease
Valuation ($)
Valuation ($)
927.5 k
Valuation ($)
N/A
Valuation ($)
41.4 m
Valuation ($)
19.6 m
Alexa Website Rank
Alexa Website Rank
283222
Alexa Website Rank
N/A
Alexa Website Rank
598654
Alexa Website Rank
721911

Financial

Net income
Net income
($19.2m) (FY, 2018)
Net income
N/A
Net income
N/A
Net income
($8.6m) (FY, 2018)

Funding

Total funding raised
Total funding raised
$ 42m
Total funding raised
$ 7m
Total funding raised
N/A
Total funding raised
$ 2.3m
For sources of this data, please see the company profile

View company profiles

OncoStem Diagnostics
HQ
Bengaluru, IN
Employees
24↓ 4% decrease

OncoStem Diagnostics is a diagnostic oncology company focused on discovering and developing novel tests for improved treatment planning.

View company
CollPlant
HQ
Ness Ziona, IL
Employees
39

CollPlant is a regenerative medicine company focused on 3D bioprinting of tissues and organs.

View company
Bio-Path Holdings
HQ
Bellaire, US
Employees
8↓ 11% decrease

Bio-Path Holdings is a clinical and preclinical stage oncology focused antisense drug development company.

View company